Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 17, 2014
Pages: 27
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M715B18D458EN
Leaflet:

Download PDF Leaflet

Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Memorial Sloan Kettering Cancer Center (MSKCC) is a healthcare service provider. The center provides cancer treatment, cancer research and cancer education programs. It conducts research in the therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genetics and genomics, molecular imaging, and tumor growth, among others. MSKCC provides diagnosis and treatment for cancer diseases, such as adrenal tumors, AIDS-associated cancers, basal cell carcinoma, benign blood disorders, bladder cancer, bone cancer, brain tumors, breast cancer and others. The center also provides predoctoral and postdoctoral training. It operates healthcare facilities, including Memorial Hospital for Cancer and Allied Diseases, New Breast and Imaging Center and Outpatient Center. MSKCC is headquartered in New York, the US.

Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Medical Devices Deals, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Memorial Sloan-Kettering Cancer Center Acquires Cabrini Medical Center
Partnerships
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Molecular Templates Enters Into Research Collaboration With Memorial Sloan-Kettering Cancer Center
Agenus Enters Into Research Agreement With Memorial Sloan-Kettering Cancer Center
Licensing Agreements
Atara Biotherapeutics Enters into Option for Licensing Agreement with Memorial Sloan Kettering Cancer Center
Sellas Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center for Vaccine to Target WT1 for Cancer
Eureka Therapeutics And Memorial Sloan-Kettering Cancer Center Enter Into Licensing Agreement With Novartis
Errant Gene Therapeutics Enters Into Licensing Agreement With MSKCC For TNS 9.55.3
MabVax Therapeutics Enters Into Licensing Agreements With Sloan-Kettering Institute For Vaccines And Lymphocytes
MabVax Therapeutics Enters Into Licensing Agreements With Sloan-Kettering Institute For Cancer Vaccines
Memorial Sloan Kettering Cancer Center - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Key Facts
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Deals By Therapy Area, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Medical Devices Deals, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Memorial Sloan-Kettering Cancer Center Acquires Cabrini Medical Center
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center
Molecular Templates Enters Into Research Collaboration With Memorial Sloan-Kettering Cancer Center
Agenus Enters Into Research Agreement With Memorial Sloan-Kettering Cancer Center
Atara Biotherapeutics Enters into Option for Licensing Agreement with Memorial Sloan Kettering Cancer Center
Sellas Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center for Vaccine to Target WT1 for Cancer
Eureka Therapeutics And Memorial Sloan-Kettering Cancer Center Enter Into Licensing Agreement With Novartis
Errant Gene Therapeutics Enters Into Licensing Agreement With MSKCC For TNS 9.55.3
MabVax Therapeutics Enters Into Licensing Agreements With Sloan-Kettering Institute For Vaccines And Lymphocytes
MabVax Therapeutics Enters Into Licensing Agreements With Sloan-Kettering Institute For Cancer Vaccines
Memorial Sloan Kettering Cancer Center, Key Competitors
Memorial Sloan Kettering Cancer Center, Key Employees
Memorial Sloan Kettering Cancer Center, Other Locations

LIST OF FIGURES

Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Memorial Sloan Kettering Cancer Center, Medical Devices Deals, 2008 to YTD 2014
Skip to top


Ask Your Question

Memorial Sloan Kettering Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: